Seeking Alpha

Obagi Medical (OMPI) falls before the bell after German drug maker Merz says it will not up the...

Obagi Medical (OMPI) falls before the bell after German drug maker Merz says it will not up the ante on Valeant Pharmaceuticals (VRX) in what was set to become a bidding war for OMPI. Merz, which called itself "a disciplined buyer" this morning, topped Valeant's original $19 per share offer last week, but will now yield to Valeant's sweetened offer of $24. OMPI shares -5.6% premarket.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs